Related Experiment Video
Updated: Jul 17, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
A beta oligomers - a decade of discovery
Dominic M Walsh1, Dennis J Selkoe
1Laboratory for Neurodegenerative Research, The Conway Institute, University College Dublin, Belfield, Dublin, Republic of Ireland. dominic.walsh@ucd.ie
Soluble amyloid beta (A beta) oligomers, not just fibrils, are increasingly recognized as key drivers of Alzheimer's disease neurotoxicity. These toxic A beta assemblies contribute to synapse loss and neuronal damage, advancing our understanding of disease mechanisms.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease pathogenesis is linked to amyloid beta-protein (A beta) accumulation.
- Historically, extracellular amyloid fibrils were considered the primary toxic species.
- Emerging evidence implicates soluble, pre-fibrillar A beta assemblies in disease progression.
Purpose of the Study:
- To review recent advancements in understanding the role of soluble oligomers in Alzheimer's disease.
- To highlight the cytotoxic effects of diffusible A beta assemblies.
- To discuss the molecular identity and impact of soluble A beta toxins.
Main Methods:
- Analysis of synthetic A beta peptides.
- Studies using cell culture models.
- Investigation of beta-amyloid precursor protein transgenic mice.
- Examination of human brain tissue.
Main Results:
- Data suggest that soluble, pre-fibrillar A beta assemblies exert deleterious effects.
- Soluble A beta forms are identified as proximate effectors of synapse loss.
- Evidence points to soluble oligomers as significant contributors to neuronal injury.
Conclusions:
- Soluble A beta oligomers play a critical role in Alzheimer's disease.
- These soluble forms are potent neurotoxins, distinct from mature fibrils.
- Further research is needed to fully elucidate the molecular mechanisms of soluble A beta toxicity.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Step-Growth Polymerization: Overview
Many natural and synthetic polymers are produced by...
Protein Organization
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...

